Introduction
Choledochal cysts are congenital dilations of the biliary tree and represent a rare diagnosis in the western hemisphere, afflicting females greater than males [1, 2] . Classically they are diagnosed in children, though it can be diagnosed in adults [4] . Presentation in adults often includes abdominal pain, nausea, vomiting, cholelithiasis, cholangitis, pancreatitis or malignancy [3, 4] . These are vague symptoms that can be misleading in the adult patient. A choledochal cysts carries up to a 10% risk of malignant transformation to cholangiocarcinoma [3] and even with resection, a patient's risk for biliary malignancy does not return to the population baseline [4] .
We present a rare case of a choledochal cyst that presented as recurrent cholangitis and choledocholithiasis years after her laparoscopic cholecystectomy. Delayed imaging revealed the choledochal cyst had fusiform dilation for the entirety of the extrahepatic bile duct, type Ia based on the Todani classification schema [5] . The patient was eventually referred to our institution for surgical management. This work has been reported in line with the SCARE criteria, a consensus on surgical case report guidelines [6] .
Presentation of case
The patient is a 50-year-old obese African-American woman with a BMI of 43 and a past medical history significant for asthma, gastroesophageal reflux, hypertension and pancreatitis who underwent cholecystectomy 6 years prior to referral to our institution. Following her initial operation, she continued to have multiple episodes of choledocholithiasis leading to cholangitis, manifested as colicky abdominal pain accompanied by nausea and vomiting. Her only work up at that point was a right upper quadrant ultrasound revealing gallbladder sludge, which led to her cholecystectomy. It was the persistence of her symptoms-abdominal pain, cholangitis and obstructive jaundice-previously attributed to chronic cholecystitis and choledocholithiasis that warranted further work up. These episodes required multiple ERCPs with intermittent biliary stent placements and stone removals for her recurrent symptoms. At the time of referral, she presented to an outside hospital with obstructive jaundice and scleral icterus, revealing hyperbilirubinemia and elevated alkaline phosphatase. Another ERCP at that time revealed something it had not previously-multiple dilated central intrahepatic ducts with a grossly dilated segment of the common hepatic duct containing large biliary stones, concerning for a type Ia choledochal cyst, with proximal biliary obstruction (Figs. 1 and 2). This corresponded to an abdominal CT performed during the same admission that revealed similar findings. Due to these diagnostic findings, she was referred to our institution for surgical management.
Upon review of her history and imaging, a complete surgical resection was indicated for her recurrent episodes of cholangitis and to reduce the risk of malignancy. To optimize her surgical outcome, we recommended weight loss and smoking cessation. She was also referred to pulmonology for risk stratification and optimization of her asthma.
She underwent an exploratory laparotomy with resection of the cyst and Roux-en-Y hepaticojejunostomy by an experienced hepatobiliary surgeon. Intra-operatively, the impressive choledochal cyst was opened and found filled with large biliary stones (Fig. 3) ; furthermore, a right posterior duct was identified which was included as a second anastomosis to the jejunal limb of the Roux-en-Y hepaticojejunostomy (Fig. 4) . Considering the impressive size of this cyst, it is remarkable that it was not identified during her laparoscopic cholecystectomy. Histological examination was done at the time of the operation via frozen section microscopy and revealed no evidence of adenocarcinoma at either margin. This was confirmed on final pathology, which revealed congested biliary mucosa with chronic inflammation and focal squamous metaplasia. The patient did well post operatively and was discharged on POD 7. At the time of this report the patient was 6 months post-op and continued to do well with resolution of her abdominal pain, nausea, vomiting and episodes of cholangitis.
Discussion
Choledochal cysts are rare in the US, afflicting 1 out of 150,000 patient, usually in their first year of life, and this report illustrates how they can lead to repeated infections, recurrent biliary stones, and biliary obstruction. More notably, this diagnosis was difficult to make, and in fact, was missed initially, despite an ultrasound, a laparoscopy and multiple ERCPs. Most choledochal cysts are diagnosed before the age of 10, and are hypothesized to develop at least partially from anomalous formation of the pancreaticobiliary ductal junction, which could result in pancreobiliary reflux and mixing [1] . This leads to cholangitis and bile duct wall destruction, in turn resulting in biliary stricture from scarring and then proximal dilation [5] . Surgical intervention is the standard treatment modality for this disease process, and a risk reduction measure for the development of cholangiocarcinoma [7] . Had this patient an MRCP prior to her cholecystectomy, she would likely have avoided multiple surgeries, and years of persistent symptoms, as well as increased cancer risk.
In this case, the patient had undergone cholecystectomy without recognition of a choledochal cyst during preoperative planning or at the time of the operation. She then continued to have episodes of choledocholithiasis with repeated ERCP interventions prior to recognition of a choledochal cyst. Once recognized, appropriate surgical intervention was performed to remove the cyst completely. Doing so has led to a resolution of the patient's symptoms and reduction in her risk for cholangiocarcinoma. Although the symptoms of choledochal cysts can be vague, practitioners must have some degree of clinical suspicion in order to obtain the appropriate diagnostic work up and to facilitate appropriate referral and treatment of choledochal cysts.
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